Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Transplantation. 2018 Mar;102(3):e115–e120. doi: 10.1097/TP.0000000000002008

Table 2.

Prevention sub-groups

N=64 No prevention group n=27 Prevention group n=37
Negative DSA n=31 Positive DSA n=6
Rituximab 0 31 6
TPE 0 22 6

DSA: donor specific antibody, TPE: therapeutic plasma exchange